share_log

Merit Medical Systems Insiders Sold US$556k Of Shares Suggesting Hesitancy

Merit Medical Systems Insiders Sold US$556k Of Shares Suggesting Hesitancy

Merit Medical Systems內部人士出售了56.6萬美元的股份,暗示出猶豫不決。
Simply Wall St ·  12/22 22:59

Merit Medical Systems, Inc. (NASDAQ:MMSI) shareholders may have reason to be concerned, as several insiders sold their shares over the past year. When evaluating insider transactions, knowing whether insiders are buying is usually more beneficial than knowing whether they are selling, as the latter can be open to many interpretations. However, when multiple insiders sell stock over a specific duration, shareholders should take notice as that could possibly be a red flag.

Merit Medical Systems, Inc.(納斯達克股票代碼:MMSI)的股東可能有理由擔心,因爲在過去的一年中,有幾位內部人士出售了他們的股票。在評估內幕交易時,了解內部人士是否在買入通常比知道他們是否在賣出更有益,因爲後者可能有多種解釋。但是,當多個內部人士在特定期限內出售股票時,股東應注意,因爲這可能是一個危險信號。

Although we don't think shareholders should simply follow insider transactions, we would consider it foolish to ignore insider transactions altogether.

儘管我們認爲股東不應該只關注內幕交易,但我們認爲完全忽視內幕交易是愚蠢的。

The Last 12 Months Of Insider Transactions At Merit Medical Systems

Merit Medical Systems最近12個月的內幕交易

In the last twelve months, the biggest single sale by an insider was when the CFO & Treasurer, Raul Parra, sold US$479k worth of shares at a price of US$74.52 per share. That means that an insider was selling shares at slightly below the current price (US$98.22). We generally consider it a negative if insiders have been selling, especially if they did so below the current price, because it implies that they considered a lower price to be reasonable. However, while insider selling is sometimes discouraging, it's only a weak signal. It is worth noting that this sale was only 46% of Raul Parra's holding.

在過去的十二個月中,內部人士最大的一次出售是財務長兼財務主管勞爾·帕拉以每股74.52美元的價格出售了價值47.9萬美元的股票。這意味着一位內部人士正在以略低於當前價格(98.22美元)的價格出售股票。如果內部人士一直在賣出,特別是如果他們賣出低於當前價格,我們通常認爲這是負數,因爲這意味着他們認爲較低的價格是合理的。但是,儘管內幕銷售有時令人沮喪,但這只是一個微弱的信號。值得注意的是,此次出售僅佔勞爾·帕拉持股量的46%。

Merit Medical Systems insiders didn't buy any shares over the last year. The chart below shows insider transactions (by companies and individuals) over the last year. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

去年,Merit Medical Systems的內部人士沒有購買任何股票。下圖顯示了去年的內幕交易(公司和個人)。如果你點擊圖表,你可以看到所有的個人交易,包括股價、個人和日期!

big
NasdaqGS:MMSI Insider Trading Volume December 22nd 2024
納斯達克GS: MMSI 內幕交易量 2024 年 12 月 22 日

If you like to buy stocks that insiders are buying, rather than selling, then you might just love this free list of companies. (Hint: Most of them are flying under the radar).

如果你喜歡買入內部人士正在買入的股票,而不是賣出,那麼你可能會喜歡這份免費的公司名單。(提示:它們中的大多數都在雷達下飛行)。

Insider Ownership Of Merit Medical Systems

Merit 醫療系統的內部所有權

I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Merit Medical Systems insiders own about US$133m worth of shares (which is 2.3% of the company). Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.

我喜歡看看內部人士在一家公司擁有多少股票,以幫助我了解他們與內部人士的看法。通常,內部人士的所有權越高,內部人士長期建立公司的可能性就越大。Merit Medical Systems內部人士擁有價值約1.33億美元的股份(佔該公司的2.3%)。大多數股東會很高興看到這種內部所有權,因爲這表明管理層的激勵措施與其他股東非常一致。

What Might The Insider Transactions At Merit Medical Systems Tell Us?

Merit Medical Systems的內幕交易可能告訴我們什麼?

There haven't been any insider transactions in the last three months -- that doesn't mean much. It's great to see high levels of insider ownership, but looking back over the last year, we don't gain confidence from the Merit Medical Systems insiders selling. Of course, the future is what matters most. So if you are interested in Merit Medical Systems, you should check out this free report on analyst forecasts for the company.

在過去的三個月中,沒有任何內幕交易——這並不意味着什麼。很高興看到高水平的內部所有權,但回顧去年,我們並沒有從Merit Medical Systems內部人士的出售中獲得信心。當然,未來才是最重要的。因此,如果你對Merit Medical Systems感興趣,你應該查看這份關於該公司分析師預測的免費報告。

But note: Merit Medical Systems may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

但請注意:Merit Medical Systems可能不是最好的買入股票。因此,來看看這份投資回報率高、債務低的有趣公司的免費清單。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

就本文而言,內部人士是那些向相關監管機構報告交易的個人。我們目前僅對公開市場交易和直接權益的私人處置進行覈算,但不包括衍生品交易或間接權益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?擔心內容嗎?直接聯繫我們。或者,發送電子郵件給編輯組(網址爲)simplywallst.com。
Simply Wall ST 的這篇文章本質上是籠統的。我們僅使用公正的方法提供基於歷史數據和分析師預測的評論,我們的文章並非旨在提供財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不會考慮最新的價格敏感型公司公告或定性材料。華爾街只是沒有持有上述任何股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論